Table of Content

1 Psoriasis and Atopic Dermatitis Drugs Market Introduction and Overview
1.1 Psoriasis and Atopic Dermatitis Drugs Definition
1.2 Market Size Analysis by Types
1.3 Market Size Analysis by Application
1.4 Research Purposes
1.5 Report Timeline
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global Psoriasis and Atopic Dermatitis Drugs Revenue and Market Share by Manufacturer
2.2 Manufacturers Psoriasis and Atopic Dermatitis Drugs Area Served, Product Types
2.3 Psoriasis and Atopic Dermatitis Drugs Market Competitive Situation and Trends
2.3.1 Psoriasis and Atopic Dermatitis Drugs Market Concentration Rate
2.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2024
2.3.3 Mergers & Acquisitions, Expansion
3 Players Profiles
3.1 Leo Pharma
3.1.1 Leo Pharma Company Profile
3.1.2 Psoriasis and Atopic Dermatitis Drugs Product Overview
3.1.3 Leo Pharma Psoriasis and Atopic Dermatitis Drugs Market Performance (2019-2024)
3.1.4 Leo Pharma Business Overview
3.2 Novartis International AG
3.2.1 Novartis International AG Company Profile
3.2.2 Psoriasis and Atopic Dermatitis Drugs Product Overview
3.2.3 Novartis International AG Psoriasis and Atopic Dermatitis Drugs Market Performance (2019-2024)
3.2.4 Novartis International AG Business Overview
3.3 Mylan
3.3.1 Mylan Company Profile
3.3.2 Psoriasis and Atopic Dermatitis Drugs Product Overview
3.3.3 Mylan Psoriasis and Atopic Dermatitis Drugs Market Performance (2019-2024)
3.3.4 Mylan Business Overview
3.4 Sanofi
3.4.1 Sanofi Company Profile
3.4.2 Psoriasis and Atopic Dermatitis Drugs Product Overview
3.4.3 Sanofi Psoriasis and Atopic Dermatitis Drugs Market Performance (2019-2024)
3.4.4 Sanofi Business Overview
3.5 Bristol-Myers Squibb Company
3.5.1 Bristol-Myers Squibb Company Company Profile
3.5.2 Psoriasis and Atopic Dermatitis Drugs Product Overview
3.5.3 Bristol-Myers Squibb Company Psoriasis and Atopic Dermatitis Drugs Market Performance (2019-2024)
3.5.4 Bristol-Myers Squibb Company Business Overview
3.6 Anacor Pharmaceutical Inc.
3.6.1 Anacor Pharmaceutical Inc. Company Profile
3.6.2 Psoriasis and Atopic Dermatitis Drugs Product Overview
3.6.3 Anacor Pharmaceutical Inc. Psoriasis and Atopic Dermatitis Drugs Market Performance (2019-2024)
3.6.4 Anacor Pharmaceutical Inc. Business Overview
3.7 Encore Dermatology
3.7.1 Encore Dermatology Company Profile
3.7.2 Psoriasis and Atopic Dermatitis Drugs Product Overview
3.7.3 Encore Dermatology Psoriasis and Atopic Dermatitis Drugs Market Performance (2019-2024)
3.7.4 Encore Dermatology Business Overview
3.8 Allergan Plc
3.8.1 Allergan Plc Company Profile
3.8.2 Psoriasis and Atopic Dermatitis Drugs Product Overview
3.8.3 Allergan Plc Psoriasis and Atopic Dermatitis Drugs Market Performance (2019-2024)
3.8.4 Allergan Plc Business Overview
3.9 Regeneron Pharmaceuticals, Inc.
3.9.1 Regeneron Pharmaceuticals, Inc. Company Profile
3.9.2 Psoriasis and Atopic Dermatitis Drugs Product Overview
3.9.3 Regeneron Pharmaceuticals, Inc. Psoriasis and Atopic Dermatitis Drugs Market Performance (2019-2024)
3.9.4 Regeneron Pharmaceuticals, Inc. Business Overview
3.10 Incyte
3.10.1 Incyte Company Profile
3.10.2 Psoriasis and Atopic Dermatitis Drugs Product Overview
3.10.3 Incyte Psoriasis and Atopic Dermatitis Drugs Market Performance (2019-2024)
3.10.4 Incyte Business Overview
3.11 Pfizer
3.11.1 Pfizer Company Profile
3.11.2 Psoriasis and Atopic Dermatitis Drugs Product Overview
3.11.3 Pfizer Psoriasis and Atopic Dermatitis Drugs Market Performance (2019-2024)
3.11.4 Pfizer Business Overview
3.12 Astellas Pharma, Inc.
3.12.1 Astellas Pharma, Inc. Company Profile
3.12.2 Psoriasis and Atopic Dermatitis Drugs Product Overview
3.12.3 Astellas Pharma, Inc. Psoriasis and Atopic Dermatitis Drugs Market Performance (2019-2024)
3.12.4 Astellas Pharma, Inc. Business Overview
4 Global Psoriasis and Atopic Dermatitis Drugs Historical and Forecast Market Analysis by Type
4.1 Global Psoriasis and Atopic Dermatitis Drugs Revenue and Market Share by Type
4.2 Global Psoriasis and Atopic Dermatitis Drugs Revenue Market Forecast by Type (2024-2030)
5 Global Psoriasis and Atopic Dermatitis Drugs Historical and Forecast Market Analysis by Application
5.1 Global Psoriasis and Atopic Dermatitis Drugs Revenue Market Share by Application (2019-2024)
5.2 Psoriasis and Atopic Dermatitis Drugs Revenue Market Forecast by Application (2024-2030)
6 Global Market Growth Trends Analysis
6.1 Global Psoriasis and Atopic Dermatitis Drugs Market Size & Forecast (2019-2030)
6.2 Psoriasis and Atopic Dermatitis Drugs Growth Trends Analysis by Regions
6.2.1 Psoriasis and Atopic Dermatitis Drugs Market Size by Regions: 2019 VS 2024 VS 2030
6.2.2 Psoriasis and Atopic Dermatitis Drugs Historic Revenue Market Size by Regions (2019-2024)
6.2.3 Psoriasis and Atopic Dermatitis Drugs Forecasted Revenue Market Size by Regions (2024-2030)
7 North America
7.1 North America Psoriasis and Atopic Dermatitis Drugs Revenue Market Size & Forecast (2019-2030)
7.2 North America Psoriasis and Atopic Dermatitis Drugs Revenue, Gross and Gross Margin (2019-2024)
7.3 North America PEST Analysis
8 Europe
8.1 Europe Psoriasis and Atopic Dermatitis Drugs Revenue Market Size & Forecast (2019-2030)
8.2 Europe Psoriasis and Atopic Dermatitis Drugs Revenue, Gross and Gross Margin (2019-2024)
8.3 Europe PEST Analysis
9 China
9.1 China Psoriasis and Atopic Dermatitis Drugs Revenue Market Size & Forecast (2019-2030)
9.2 China Psoriasis and Atopic Dermatitis Drugs Revenue, Gross and Gross Margin (2019-2024)
9.3 China PEST Analysis
10 Japan
10.1 Japan Psoriasis and Atopic Dermatitis Drugs Revenue Market Size & Forecast (2019-2030)
10.2 Japan Psoriasis and Atopic Dermatitis Drugs Revenue, Gross and Gross Margin (2019-2024)
10.3 Japan PEST Analysis
11 Korea
11.1 Korea Psoriasis and Atopic Dermatitis Drugs Revenue Market Size & Forecast (2019-2030)
11.2 Korea Psoriasis and Atopic Dermatitis Drugs Revenue, Gross and Gross Margin (2019-2024)
11.3 Korea PEST Analysis
12 Southeast Asia
12.1 Southeast Asia Psoriasis and Atopic Dermatitis Drugs Revenue Market Size & Forecast (2019-2030)
12.2 Southeast Asia Psoriasis and Atopic Dermatitis Drugs Revenue, Gross and Gross Margin (2019-2024)
12.3 Southeast Asia PEST Analysis
13 India
13.1 India Psoriasis and Atopic Dermatitis Drugs Revenue Market Size & Forecast (2019-2030)
13.2 India Psoriasis and Atopic Dermatitis Drugs Revenue, Gross and Gross Margin (2019-2024)
13.3 India PEST Analysis
14 South America
14.1 South America Psoriasis and Atopic Dermatitis Drugs Revenue Market Size & Forecast (2019-2030)
14.2 South America Psoriasis and Atopic Dermatitis Drugs Revenue, Gross and Gross Margin (2019-2024)
14.3 South America PEST Analysis
15 Middle East & Africa
15.1 Middle East & Africa Psoriasis and Atopic Dermatitis Drugs Revenue Market Size & Forecast (2019-2030)
15.2 Middle East & Africa Psoriasis and Atopic Dermatitis Drugs Revenue, Gross and Gross Margin (2019-2024)
15.3 Middle East & Africa PEST Analysis
16 Psoriasis and Atopic Dermatitis Drugs Business Cost Analysis
16.1 Proportion of Business Cost Structure
16.1.1 Labor Cost
16.1.2 Operating Expenses
16.2 Psoriasis and Atopic Dermatitis Drugs Industrial Chain Analysis
17 Psoriasis and Atopic Dermatitis Drugs Industry Dynamic Analysis
17.1 Psoriasis and Atopic Dermatitis Drugs Market Trends Analysis
17.2 Psoriasis and Atopic Dermatitis Drugs Market Drivers Analysis
17.3 Psoriasis and Atopic Dermatitis Drugs Market Challenges Analysis
17.4 Psoriasis and Atopic Dermatitis Drugs Market Restraints Analysis